168 related articles for article (PubMed ID: 28470096)
21. The role of microRNAs in the pathogenesis of endometrial cancer: a systematic review.
Sianou A; Galyfos G; Moragianni D; Andromidas P; Kaparos G; Baka S; Kouskouni E
Arch Gynecol Obstet; 2015 Aug; 292(2):271-82. PubMed ID: 25697925
[TBL] [Abstract][Full Text] [Related]
22. Endometrial carcinoma: pathology and genetics.
Prat J; Gallardo A; Cuatrecasas M; Catasús L
Pathology; 2007 Feb; 39(1):72-87. PubMed ID: 17365824
[TBL] [Abstract][Full Text] [Related]
23. Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer.
Banno K; Yanokura M; Susumu N; Kawaguchi M; Hirao N; Hirasawa A; Tsukazaki K; Aoki D
Oncol Rep; 2006 Dec; 16(6):1189-96. PubMed ID: 17089036
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of E-cadherin expression and CDH1 promoter methylation in patients with endometrial carcinoma.
Yi TZ; Guo J; Zhou L; Chen X; Mi RR; Qu QX; Zheng JH; Zhai L
Cancer Invest; 2011 Jan; 29(1):86-92. PubMed ID: 20874004
[TBL] [Abstract][Full Text] [Related]
25. Hypermethylation of selected genes in endometrial carcinogenesis.
Visnovsky J; Fiolka R; Kudela E; Slavik P; Krkoska M; Lasabová Z; Danko J
Neuro Endocrinol Lett; 2013; 34(7):675-80. PubMed ID: 24464006
[TBL] [Abstract][Full Text] [Related]
26. Common DNA methylation dynamics in endometriod adenocarcinoma and glioblastoma suggest universal epigenomic alterations in tumorigenesis.
Karlow JA; Miao B; Xing X; Wang T; Zhang B
Commun Biol; 2021 May; 4(1):607. PubMed ID: 34021236
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic considerations for endometrial cancer prevention, diagnosis and treatment.
Zhou XC; Dowdy SC; Podratz KC; Jiang SW
Gynecol Oncol; 2007 Oct; 107(1):143-53. PubMed ID: 17692907
[TBL] [Abstract][Full Text] [Related]
28. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.
Liao X; Siu MK; Chan KY; Wong ES; Ngan HY; Chan QK; Li AS; Khoo US; Cheung AN
Int J Cancer; 2008 Jul; 123(2):296-302. PubMed ID: 18404674
[TBL] [Abstract][Full Text] [Related]
29. Endometrial cancer--prospective potential to make diagnostic process more specific.
Repiska V; Radzo E; Biro C; Bevizova K; Bohmer D; Galbavy S
Neuro Endocrinol Lett; 2010; 31(4):474-6. PubMed ID: 20802453
[TBL] [Abstract][Full Text] [Related]
30. Cancer epigenetics in solid organ tumours: A primer for surgical oncologists.
Drake TM; Søreide K
Eur J Surg Oncol; 2019 May; 45(5):736-746. PubMed ID: 30745135
[TBL] [Abstract][Full Text] [Related]
31. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic regulation and cancer (review).
Chen QW; Zhu XY; Li YY; Meng ZQ
Oncol Rep; 2014 Feb; 31(2):523-32. PubMed ID: 24337819
[TBL] [Abstract][Full Text] [Related]
33. Expression, Epigenetic and Genetic Changes of HNF1B in Endometrial Lesions.
Němejcová K; Tichá I; Kleiblová P; Bártů M; Cibula D; Jirsová K; Dundr P
Pathol Oncol Res; 2016 Jul; 22(3):523-30. PubMed ID: 26685938
[TBL] [Abstract][Full Text] [Related]
34. Epigenetics and genetics in endometrial cancer: new carcinogenic mechanisms and relationship with clinical practice.
Banno K; Kisu I; Yanokura M; Masuda K; Ueki A; Kobayashi Y; Susumu N; Aoki D
Epigenomics; 2012 Apr; 4(2):147-62. PubMed ID: 22449187
[TBL] [Abstract][Full Text] [Related]
35. Whole-Genome DNA Methylation Profiling Identifies Epigenetic Signatures of Uterine Carcinosarcoma.
Li J; Xing X; Li D; Zhang B; Mutch DG; Hagemann IS; Wang T
Neoplasia; 2017 Feb; 19(2):100-111. PubMed ID: 28088687
[TBL] [Abstract][Full Text] [Related]
36. Absence of MGMT promoter methylation in endometrial cancer.
Rimel BJ; Huettner P; Powell MA; Mutch DG; Goodfellow PJ
Gynecol Oncol; 2009 Jan; 112(1):224-8. PubMed ID: 18973931
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of estrogen receptor by the methylation of the estrogen receptor gene in endometrial carcinoma.
Shiozawa T; Itoh K; Horiuchi A; Konishi I; Fujii S; Nikaido T
Anticancer Res; 2002; 22(1A):139-43. PubMed ID: 12017277
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic regulation in the carcinogenesis of cholangiocarcinoma.
Chiang NJ; Shan YS; Hung WC; Chen LT
Int J Biochem Cell Biol; 2015 Oct; 67():110-4. PubMed ID: 26100596
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic silencing of cell cycle regulatory genes during 3-methylcholanthrene and diethylnitrosamine-induced multistep rat lung cancer.
Liu WB; Liu JY; Ao L; Zhou ZY; Zhou YH; Cui ZH; Cao J
Mol Carcinog; 2010 Jun; 49(6):556-65. PubMed ID: 20512841
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival.
Cosgrove CM; Cohn DE; Hampel H; Frankel WL; Jones D; McElroy JP; Suarez AA; Zhao W; Chen W; Salani R; Copeland LJ; O'Malley DM; Fowler JM; Yilmaz A; Chassen AS; Pearlman R; Goodfellow PJ; Backes FJ
Gynecol Oncol; 2017 Sep; 146(3):588-595. PubMed ID: 28709704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]